Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice

被引:19
作者
Bigini, Paolo
Gardoni, Fabrizio
Barbera, Sara
Cagnotto, Alfredo
Fumagalli, Elena
Longhi, Annalisa
Corsi, Massimiliano M.
Di Luca, Monica
Mennini, Tiziana
机构
[1] Mario Negri Inst Pharmacol Res, Lab Receptor Pharmacol, Dept Biochem & Mol Pharmacol, I-20157 Milan, Italy
[2] Univ Milan, Ctr Excellenc Neurodegenerat Dis, I-20133 Milan, Italy
[3] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy
[4] Univ Milan, Inst Gen Pathol, Milan, Italy
关键词
D O I
10.1186/1471-2202-7-71
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The localisation of AMPA and NMDA receptor subunits was studied in a model of degeneration of cervical spinal motoneurons, the wobbler mouse. Cervical regions from early or late symptomatic wobbler mice (4 or 12 weeks of age) were compared to lumbar tracts (unaffected) and to those of healthy mice. Results: No differences were found in the distribution of AMPA and NMDA receptor subunits at both ages. Western blots analysis showed a trend of reduction in AMPA and NMDA receptor subunits, mainly GluR2 and NR2A, exclusively in the cervical region of late symptomatic mice in the triton-insoluble post-synaptic fraction but not whole homogenates. Colocalisation experiments evidenced the expression of GluR1 and NR2A receptors in activated astrocytes from the cervical spinal cord of wobbler mice, GluR2 did not colocalise with GFAP positive cells. No differences were found in the expression of AMPA and NMDA receptor subunits in the lumbar tract of wobbler mice, where neither motoneuron loss nor reactive gliosis occurs. Conclusion: In late symptomatic wobbler mice altered levels of GluR1 and NR2A receptor subunits may be a consequence of motoneuron loss rather than an early feature of motoneuron vulnerability.
引用
收藏
页数:12
相关论文
共 27 条
[1]   Glutamate transporters in the spinal cord of the wobbler mouse [J].
Bigini, P ;
Bastone, A ;
Mennini, T .
NEUROREPORT, 2001, 12 (09) :1815-1820
[2]   PLASMINOGEN ACTIVATORS IN THE NEUROMUSCULAR SYSTEM OF THE WOBBLER MUTANT MOUSE [J].
BLONDET, B ;
BARLOVATZMEIMON, G ;
FESTOFF, BW ;
SORIA, C ;
SORIA, J ;
RIEGER, F ;
HANTAI, D .
BRAIN RESEARCH, 1992, 580 (1-2) :303-310
[4]  
CAMBIER D, 1995, J NEUROCHEM, V65, P1199
[5]  
Canton T, 2001, J PHARMACOL EXP THER, V299, P314
[6]   Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis [J].
Cudkowicz, ME ;
McKennaYasek, D ;
Sapp, PE ;
Chin, W ;
Geller, B ;
Hayden, DL ;
Schoenfeld, DA ;
Hosler, BA ;
Horvitz, HR ;
Brown, RH .
ANNALS OF NEUROLOGY, 1997, 41 (02) :210-221
[7]   The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis [J].
Deniselle, MCG ;
González, SL ;
Lima, AE ;
Wilkin, G ;
De Nicola, AF .
NEUROCHEMICAL RESEARCH, 1999, 24 (01) :1-8
[8]  
Falconer D., 1956, MOUSE NEWS LETT, V15, P23
[9]   NMDA receptor composition differs among anatomically diverse malformations of cortical development [J].
Finardi, Adele ;
Gardoni, Fabrizio ;
Bassanini, Stefama ;
Lasio, Giovanni ;
Cossu, Massimo ;
Tassi, Laura ;
Caccia, Claudio ;
Taroni, Franco ;
LoRusso, Giorgio ;
Di Luca, Monica ;
Battaglia, Giorgio .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (09) :883-893
[10]   Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease [J].
Fumagalli, E ;
Bigini, P ;
Barbera, S ;
De Paola, M ;
Mennini, T .
EXPERIMENTAL NEUROLOGY, 2006, 198 (01) :114-128